NEW YORK (GenomeWeb News) – The National Cancer Institute will fund two-year grants with up to $275,000 to researchers developing new molecular methods for cancer detection, diagnosis, and prognosis.
NCI said it plans to fund studies focused on methods of detecting specific cancer characteristics and which can be used in clinical management of cancer patients or individuals who are at risk of developing cancer.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.